While early-generation nanomedicines (such as liposomal mifamurtide) have historical clinical applications in osteosarcoma, and some nanocarriers like epirubicin micelles (NC-6300) have entered early-phase trials for general sarcomas, none of the advanced, multi-targeted nanomedicine-immunotherapy combination platforms discussed in this review have yet entered active clinical trials specifically for osteosarcoma
Best fit Cellular repair, Skin quality, Healthy aging Epithalon (Epitalon) should be evaluated by goal fit, safety fit, evidence strength, and provider oversight
The fabrication of BTPE-NO 2 @F127, including the chemical synthesis and characterization, requires ~17 d, while the in vitro validation of its H 2 O 2 responsiveness takes ~5 d
10.1038/s41467-022-34716-5 141 YinH
pneumoniae on the growth of N
Matre P, Samudio I, Jacamo R, Wang Y, Wang J, Davis RE, Su X, Schindela S, Newman R, Hu J, Haferlach T, Andreeff M , Flores ER, Schimmer A, Konopleva M